Joseph K. Belanoff - Chief Executive Officer, Director at Corcept Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
CORT on Nasdaq
All Insider Reports
All Insider Reports

Joseph K. Belanoff - trading volume in the past year for Corcept Therapeutics Inc

Holdings reported by Joseph K. Belanoff for Corcept Therapeutics Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.78M $238M $85.67 Oct 1, 2025 Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
Stock option (right to buy) 350K Feb 28, 2025 Direct Common Stock

Transactions reported by Joseph K. Belanoff for Corcept Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.